Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation
- PMID: 28795873
- DOI: 10.1080/03009742.2017.1340512
Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation
Similar articles
-
Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.Scand J Rheumatol. 2018 Jul;47(4):334-335. doi: 10.1080/03009742.2017.1369155. Epub 2017 Oct 18. Scand J Rheumatol. 2018. PMID: 29043891 No abstract available.
-
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.Mod Rheumatol Case Rep. 2021 Jan;5(1):101-107. doi: 10.1080/24725625.2020.1832755. Epub 2020 Oct 20. Mod Rheumatol Case Rep. 2021. PMID: 33019894 Free PMC article.
-
Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.Acta Clin Belg. 2018 Dec;73(6):413-417. doi: 10.1080/17843286.2017.1420521. Epub 2017 Dec 29. Acta Clin Belg. 2018. PMID: 29287518
-
Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features.J Am Acad Dermatol. 2018 Apr;78(4):776-785. doi: 10.1016/j.jaad.2017.12.010. Epub 2017 Dec 9. J Am Acad Dermatol. 2018. PMID: 29229575 Review.
-
Macrophage activation syndrome in adult dermatomyositis: a case-based review.Rheumatol Int. 2020 Jul;40(7):1151-1162. doi: 10.1007/s00296-020-04590-9. Epub 2020 Apr 30. Rheumatol Int. 2020. PMID: 32356114 Review.
Cited by
-
Retinal microvascular and microstructural alterations in the diagnosis of dermatomyositis: a new approach.Front Med (Lausanne). 2023 May 25;10:1164351. doi: 10.3389/fmed.2023.1164351. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37305140 Free PMC article.
-
Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies.Biomedicines. 2022 Nov 18;10(11):2969. doi: 10.3390/biomedicines10112969. Biomedicines. 2022. PMID: 36428536 Free PMC article.
-
Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation.Cureus. 2022 Aug 10;14(8):e27839. doi: 10.7759/cureus.27839. eCollection 2022 Aug. Cureus. 2022. PMID: 36106216 Free PMC article.
-
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.Front Immunol. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352. eCollection 2021. Front Immunol. 2021. PMID: 34745149 Free PMC article. Review.
-
Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman.Front Med (Lausanne). 2021 Oct 1;8:742823. doi: 10.3389/fmed.2021.742823. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34660647 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
